Emergence of New Delhi Metallo-Beta-Lactamase (NDM-1) and Klebsiella pneumoniae Carbapenemase (KPC-2) in South Africa

被引：78

作者：

Brink, Adrian J. ^{[1
]}

Coetzee, Jennifer ^{[2
]}

Clay, Cornelis G. ^{[2
]}

Sithole, Sindi ^{[3
]}

Richards, Guy A. ^{[4
,5
]}

Poirel, Laurent ^{[6
,7
]}

Nordmann, Patrice ^{[6
,7
]}

机构：

[1] Milpark Hosp, Ampath Natl Lab Serv, Dept Clin Microbiol, Johannesburg, South Africa

[2] Natl Referral Lab, Ampath Natl Lab Serv, Dept Clin Microbiol & Mol Biol, Centurion, South Africa

[3] Glynwood Hosp, Ampath Natl Lab Serv, Dept Clin Microbiol, Johannesburg, South Africa

[4] Charlotte Maxeke Johannesburg Acad Hosp, Dept Crit Care, Johannesburg, South Africa

[5] Univ Witwatersrand, Johannesburg, South Africa

[6] Hop Bicetre, AP HP, Fac Med, Serv Bacteriol Virol,INSERM Emerging Resistance A, K Bicetre, France

[7] Univ Paris 11, K Bicetre, France

来源：

JOURNAL OF CLINICAL MICROBIOLOGY | 2012年 / 50卷 / 02期

关键词：

RESISTANCE; INFECTION; SPREAD;

D O I：

10.1128/JCM.05956-11

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

This report documents emergence of New Delhi metallo-beta-lactamase (NDM-1) and Klebsiella pneumoniae carbapenemase (KPC-2) in K. pneumoniae and Enterobacter cloacae in South Africa. NDM-1 producers have not been described in South Africa, and this is the first instance that KPC producers have been identified in Africa. The two patients infected with these carbapenemase-producing bacteria demised.

引用

页码：525 / 527

页数：3

共 17 条

[1] [Anonymous], 2011, Performance standards for antimicrobial disk susceptibility tests
[2] approved standard M2-A11, V11th
[3] Controlling the spread of carbapenemase-producing Gram-negatives: therapeutic approach and infection control
Carmeli, Y.
Akova, M.
Cornaglia, G.
Daikos, G. L.
Garau, J.
Harbarth, S.
Rossolini, G. M.
Souli, M.
Giamarellou, H.
[J]. CLINICAL MICROBIOLOGY AND INFECTION, 2010, 16 (02) : 102 - 111
[4] In vivo development of ertapenem resistance in a patient with pneumonia caused by Klebsiella pneumoniae with an extended-spectrum β-lactamase
Elliott, E
Brink, AJ
van Greune, J
Els, Z
Woodford, N
Turton, J
Warner, M
Livermore, DM
[J]. CLINICAL INFECTIOUS DISEASES, 2006, 42 (11) : E95 - E98
[5] European Committee on Antimicrobial Susceptibility Testing, 2009, BREAKP TABL INT MICS
[6] Grundmann H, 2010, EUROSURVEILLANCE, V15, P22
[7] Rapid detection of blaKPC carbapenemase genes by real-time PCR
Hindiyeh, Musa
Smollen, Gill
Grossman, Zehava
Ram, Daniela
Davidson, Yehudit
Mileguir, Fernando
Vax, Marina
Ben David, Debbie
Tal, Ilana
Rahav, Galia
Shamiss, Ari
Mendelson, Ella
Keller, Nathan
[J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2008, 46 (09) : 2879 - 2883
[8] Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection
Hirsch, Elizabeth B.
Tam, Vincent H.
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2010, 65 (06) : 1119 - 1125
[9] Antibiotic use and the risk of carbapenem-resistant extended-spectrum-β-lactamase-producing Klebsiella pneumoniae infection in hospitalized patients: results of a double case-control study
Kritsotakis, Evangelos I.
Tsioutis, Constantinos
Roumbelaki, Maria
Christidou, Athanasia
Gikas, Achilleas
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2011, 66 (06) : 1383 - 1391
[10] Nordmann P, 2011, J CLIN MICROBIOL, V41, P798

← 1 2 →